Immunitrack Overview

  • Founded
  • 2013

  • Status
  • Private

  • Employees
  • 17

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Immunitrack General Information


Provider of AI-based prediction and assessment platform intended to assist biotech and pharma companies. The company offers contracted research to the pharmaceutical industry predicting how the immune system reacts to different pharmaceuticals, by producing reagents that can be used to examine the immune system's reaction, enabling biotech and pharma companies to produce new biologics and vaccines easily.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Primary Office
  • Lersø Parkallé 42
  • 2100 Copenhagen
  • Denmark
+45 28 00 00 00

Immunitrack Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunitrack Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 24-Jun-2020 00.000 Completed Generating Revenue
3. Grant 08-Aug-2019 00000 00.000 Completed Generating Revenue
2. Seed Round 05-Jun-2018 $4.12M $4.12M Completed Generating Revenue
1. Accelerator/Incubator 24-Nov-2016 Completed Generating Revenue
To view Immunitrack’s complete valuation and funding history, request access »

Immunitrack Executive Team (2)

Name Title Board Seat Contact Info
Stephan Thorgrimsen Ph.D Co-Founder, Chief Executive Officer & Board Member
Sune Justensen Ph.D Co-Founder, Chief Scientific Officer & Board Member
To view Immunitrack’s complete executive team members history, request access »

Immunitrack Board Members (6)

Name Representing Role Since
Karin Absalonsen Self Chairman 000 0000
Li Lim Self Board Member 000 0000
Robin Campbell Ph.D Self Board Member 000 0000
Stephan Thorgrimsen Ph.D Immunitrack Co-Founder, Chief Executive Officer & Board Member 000 0000
Stephen Gibbons Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Immunitrack Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunitrack Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Invest Horizon Government 000 0000 000000 0
Eurostars Government 000 0000 000000 0
Blenheim Capital (Investor) Venture Capital Minority 000 0000 000000 0
Accelerace Accelerator/Incubator Minority 000 0000 000000 0
To view Immunitrack’s complete investors history, request access »